From January 1, 2023 to March 31, 2023, the company has repurchased 950,000 shares, representing 0.2% for CNY 8.04 million. With this, the company has completed the repurchase of 7,380,000 shares, representing 1.51% for CNY 69.09 million under the buyback announced on May 18, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.1 CNY | -6.03% | -4.71% | +9.91% |
25/04 | Guangdong VTR Bio-Tech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
25/04 | Guangdong VTR Bio-Tech Co., Ltd. Proposes Final Cash Dividend for the Year 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
+9.91% | 571M | |
+19.15% | 12.44B | |
+3.76% | 5.98B | |
+4.98% | 5.27B | |
+12.24% | 4.62B | |
-19.13% | 2.71B | |
+2.71% | 1.93B | |
-13.33% | 1.24B | |
-17.39% | 942M | |
-9.93% | 935M |
- Stock Market
- Equities
- 300381 Stock
- News Guangdong VTR Bio-Tech Co., Ltd.
- Tranche Update on Guangdong VTR Bio-Tech Co., Ltd.'s Equity Buyback Plan announced on May 18, 2022.